Emory University physician and deputy director of the Winship Cancer Institute of Emory University Fadlo R. Khuri, MD, will be awarded the prestigious Richard and Hinda Rosenthal Memorial Award from the American Association for Cancer Research. The award will recognize his groundbreaking accomplishments and contributions as a researcher of lung and aerodigestive medical oncology.
"Fadlo's leadership in lung and head and neck cancer research is legendary, and he has helped advance our understanding of the nation's number one cancer killer by introducing novel therapeutic agents that have changed how people live with this disease," said executive director of the Winship Cancer Institute Walter J. Curran. "More than any other person I can think of, he has changed how we think about lung cancer – and how people live with this disease as a chronic, manageable illness in many cases, rather than as a death sentence. I am thrilled that he is receiving this prestigious national award for the tireless work he has invested in patients with lung and other aerodigestive cancers."
In addition to being one of the world’s foremost experts in this field, Khuri is also credited with attaining the National Cancer Institute (NCI) designation to Winship Cancer Institute in 2009. Khuri also helped to drastically increase peer-reviewed funding for cancer at Emory University. In 2000, the research funding for cancer totaled $7.4 million, but Emory University benefited from more than $30 million in cancer research funding in 2011. Khuri also helped increase the number of patients enrolled in therapeutic clinical trials. In 2001, the number was 143, but trials have enrolled more than 500 patients annually in the last three years.
Dr. Fadlo R. Khuri and colleagues at Winship Cancer Institute
Image courtesy of Emory University
According to recent funding statistics, Emory University has a wealth of funding available for laboratory equipment sales. In total, Emory University received $274.2 million in research funding from the NSF and NIH in 2012. The NSF awarded the university $10.6 million of research funding in 2012. Distributed among various departments at Emory University, the research funding went towards life science projects in disciplines such as neural systems, genetic mechanisms, systems and synthetic biology, physiology and structural systems, and cellular dynamics and function. Emory University was ranked 22nd by the NSF in 2009 for total R&D expenditures in the life sciences, having spent a total of $417 million. Over the past five years, Emory University’s funding has increased by more than 52 percent.
In addition to receiving $10.6 million of NSF research funding, Emory University was also awarded $263.6 million in funding from the NIH. In 2011, the NIH ranked Emory University 18th for direct plus indirect costs excluding R&D contracts and ARRA awards, making the total $273.4 million. The 2012 NIH research money was also distributed among a number of different departments at Emory University, including anatomy/cell biology, biochemistry, biology, biomedical engineering, biostatistics, chemistry, internal medicine, microbiology, pharmacology and veterinary science. For the convenience of our readers, we have compiled a list of the top NIH-funded life science departments at Emory University. For a full list of NIH-funded departments at Emory University, please visit the NIH website.
2012 NIH Research Funding at Emory University
If you are a biotechnology vendor or lab supplier interested in learning more about the laboratory equipment sales market at Emory University, Biotechnology Calendar, Inc. invites you to attend our annual Atlanta BioResearch Product Faire™ Event on April 18, 2013. Biotechnology Calendar, Inc. is a full-service science research marketing and events planning company that has been hosting trade shows at top university campuses for 20 years. To learn more about funding statistics at Emory University, click on the button below. If you’d like to learn about a laboratory equipment sales market at a university closer to home, we encourage you to check out our 2013 calendar of events.